Efficacy of induction therapy on acute rejection and graft outcomes in African American kidney transplantation
Authors:
- 20 January 2010
- journal article
- Published by Wiley in Clinical Transplantation
- Vol. 24 (1) , 40-47
Abstract
BACKGROUND:\ud \ud African Americans (AA) have higher rejection rates and poorer graft outcomes compared to non-AAs. Induction therapy is yet unproven in this high risk population.\ud METHODS:\ud \ud This retrospective study compared the efficacy of induction therapy [IL-2 receptor antibodies (IL2RA) or thymoglobulin] vs. no induction.\ud RESULTS:\ud \ud One hundred and seventy-five AA patients were included in this analysis. Patients were well matched for demographic and immunologic characteristics in the non-induction and IL2RA induction groups; the Thymoglobulin induction group had significantly higher risk patients. Significantly fewer episodes of acute rejection occurred at one yr in patients treated with thymoglobulin and IL2RA vs. no induction (18% vs. 47%, p = 0.003, 26% vs. 47%, p = 0.02). Three yr graft survival was significantly improved in the IL2RA group compared to the non-induction group (85% vs. 68%, p = 0.032). Despite the thymoglobulin group being at high risk, they had similar graft survival rates compared to both the IL2RA group (76% vs. 85%, p = 0.18) and the non-induction group (76% vs. 68%, p = 0.48). Multivariate analysis demonstrated that induction therapy (combining IL2RA and thymoglobulin) independently reduced the risk of both acute rejection and graft loss.\ud CONCLUSION:\ud \ud The use and type of induction therapy in AA patients significantly reduces acute rejection rates and may improve long-term graft outcomes in AA patientsKeywords
This publication has 18 references indexed in Scilit:
- The Rocky Road of Limited Immunosuppression for Renal Transplantation in African AmericansTransplantation, 2007
- Rabbit Antithymocyte Globulin versus Basiliximab in Renal TransplantationNew England Journal of Medicine, 2006
- Long-Term Results of Monoclonal Anti-Il2-Receptor Antibody Versus Polyclonal Antilymphocyte Antibodies as Induction Therapy in Renal TransplantationTransplantation Proceedings, 2006
- Kidney and Pancreas Transplantation in the United States, 1995–2004American Journal of Transplantation, 2006
- Immunosuppression: Evolution in Practice and Trends, 1994–2004American Journal of Transplantation, 2006
- Influence of Race on Kidney Transplant Outcomes within and outside the Department of Veterans AffairsJournal of the American Society of Nephrology, 2005
- Renal Transplantation in Black AmericansNew England Journal of Medicine, 2000
- Racial Disparities in Access to Renal Transplantation — Clinically Appropriate or Due to Underuse or Overuse?New England Journal of Medicine, 2000
- The Effect of Patients' Preferences on Racial Differences in Access to Renal TransplantationNew England Journal of Medicine, 1999
- RACIAL DIFFERENCES IN RENAL TRANSPLANTATION AFTER IMMUNOSUPPRESSION WITH TACROLIMUS VERSUS CYCLOSPORINE1Transplantation, 1998